AnterogenCoLtd Valuation
| 065660 Stock | KRW 15,330 30.00 0.20% |
At this time, the firm appears to be undervalued. AnterogenCoLtd shows a prevailing Real Value of W4074.09 per share. The current price of the firm is W15330.0. Our model approximates the value of AnterogenCoLtd from analyzing the firm fundamentals such as Profit Margin of (1.32) %, current valuation of 836.51 B, and Return On Equity of -5.92 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that AnterogenCoLtd's price fluctuation is very steady at this time. Calculation of the real value of AnterogenCoLtd is based on 3 months time horizon. Increasing AnterogenCoLtd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AnterogenCoLtd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AnterogenCoLtd Stock. However, AnterogenCoLtd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15330.0 | Real 4074.09 | Hype 0.0 | Naive 15026.65 |
The real value of AnterogenCoLtd Stock, also known as its intrinsic value, is the underlying worth of AnterogenCoLtd Company, which is reflected in its stock price. It is based on AnterogenCoLtd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AnterogenCoLtd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AnterogenCoLtd helps investors to forecast how AnterogenCoLtd stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AnterogenCoLtd more accurately as focusing exclusively on AnterogenCoLtd's fundamentals will not take into account other important factors: AnterogenCoLtd Total Value Analysis
AnterogenCoLtd is presently forecasted to have takeover price of 836.51 B with market capitalization of 108.41 B, debt of 0, and cash on hands of 6.97 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AnterogenCoLtd fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 836.51 B | 108.41 B | 0 | 6.97 B |
AnterogenCoLtd Investor Information
About 21.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. ,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on AnterogenCoLtd please contact the company at 82 2 2104 0391 or go to http://anterogen.com.AnterogenCoLtd Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AnterogenCoLtd has an asset utilization ratio of 5.94 percent. This suggests that the Company is making W0.0594 for each dollar of assets. An increasing asset utilization means that AnterogenCoLtd is more efficient with each dollar of assets it utilizes for everyday operations.AnterogenCoLtd Ownership Allocation
The market capitalization of AnterogenCoLtd is W108.41 Billion. AnterogenCoLtd retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.AnterogenCoLtd Profitability Analysis
The company reported the revenue of 8.12 B. Net Loss for the year was (553.98 M) with profit before overhead, payroll, taxes, and interest of 1.72 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AnterogenCoLtd's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AnterogenCoLtd and how it compares across the competition.
About AnterogenCoLtd Valuation
The stock valuation mechanism determines the current worth of AnterogenCoLtd on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AnterogenCoLtd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AnterogenCoLtd based exclusively on its fundamental and basic technical indicators. By analyzing AnterogenCoLtd's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AnterogenCoLtd's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AnterogenCoLtd. We calculate exposure to AnterogenCoLtd's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AnterogenCoLtd's related companies.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct AnterogenCoLtd's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AnterogenCoLtd's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AnterogenCoLtd's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AnterogenCoLtd's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AnterogenCoLtd's revenue streams: Identify AnterogenCoLtd's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AnterogenCoLtd's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AnterogenCoLtd's growth potential: Evaluate AnterogenCoLtd's management, business model, and growth potential.
- Determine AnterogenCoLtd's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AnterogenCoLtd's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |